Albendazole 400 mg single dose vs albendazole 400 mg multiple doses
Adverse events · children and adults
1 finding from 1 review
- no estimate extracted3 studies · 316 participantsModerate
Findings
What do systematic reviews say?
8 questions · 8 findings · 3 reviews
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 25%Moderate 4 · 50%High 2 · 25%
Albendazole 400 mg single dose vs mebendazole 500 mg single dose
Adverse events · children and adults
1 finding from 1 review
- no estimate extracted5 studies · 1902 participantsLow
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
- Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes onlyRR 0.95 [0.61, 1.48]2 studies · 678 participantsModerate
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (high certainty).
1 finding from 1 review
- Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes onlyRR 0.94 [0.79, 1.11]4 studies · 1589 participantsHigh
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
- Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes onlyRR 1.16 [0.77, 1.74]1 study · 627 participantsModerate
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (high certainty).
1 finding from 1 review
- Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes onlyRR 0.97 [0.84, 1.13]6 studies · 2894 participantsHigh
Intervention not reported
Adverse events report of adverse events · patients with treating strongyloides infection
The intervention showed no clear difference in adverse events report of adverse events (low certainty).
1 finding from 1 review
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection 2016 · Cochrane Headline outcomes onlyRR 0.8 [0.59, 1.09]4 studies · 518 participantsLow
Intervention not reported
Adverse events report of adverse events · patients with treating strongyloides infection
The intervention probably leads to lower adverse events report of adverse events (moderate certainty).
1 finding from 1 review
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection 2016 · Cochrane Headline outcomes onlyRR 0.31 [0.2, 0.5]3 studies · 507 participantsModerate